Cardiogenic shock (CS) is characterized by low cardiac output and sustained tissue
hypoperfusion that may result in end-organ dysfunction and death. CS is associated with …

Background Cardiogenic shock remains highly associated with early mortality, with mortality
often exceeding 50%. We sought to determine the association between prognostic factors …

Objectives: This observational study was conducted to investigate capillary refill time (CRT)
during the early phase of ICU admission in relationship with microvascular flow alteration …

Background Reliable predictors of outcomes in venoarterial extracorporeal membrane
oxygenation (VA-ECMO) therapy are limited. While elevated lactate levels over time have …

Background Cardiogenic shock (CS) is a state of end-organ hypoperfusion related to
cardiac dysfunction. Current guidelines recommend consideration of inotrope therapy in …

Review of the current literature fails to show significant mortality benefit with any specific
vasopressor or inotropic in CS patients. The upcoming DOREMI 2 and levosimendan versus …

Cardiogenic shock is a state of reduced cardiac output leading to hypotension, pulmonary
congestion, and hypoperfusion of tissues and vital organs. Despite the advances in …

Hemodynamic assessment of patients with pulmonary embolism (PE) remains a
fundamental component of early risk stratification that in turn, influences subsequent …

Cardiogenic shock (CS) is characterized by the presence of a state of tissue hypoperfusion
secondary to ventricular dysfunction. Hemodynamic monitoring allows us to obtain …

Aims Veno‐arterial extracorporeal membrane oxygenation (VA‐ECMO) is a life‐saving
procedure for supporting patients with cardiogenic shock after cardiac surgery. This work …